Massimo Russo

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Factors predicting survival in ALS: a multicenter Italian study

Andrea Calvo, Cristina Moglia, Christian Lunetta et al. · Journal of Neurology · 2016 · 119 citations · Full text

Life Sciences, Neurology, Neuroscience +11

Hospital-acquired malnutrition in children with mild clinical conditions

Angelo Campanozzi, Massimo Russo, Alessandra Catucci et al. · Nutrition · 2009 · 112 citations

Agriculture, Child Health, Pediatrics +14

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

Andrea Cortese, Giuseppe Vita, Marco Luigetti et al. · Journal of Neurology · 2016 · 96 citations · Full text

Medicine, Neurology, Pathology +4

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

Anna Mazzeo, Massimo Russo, Gianluca Di Bella et al. · Journal of Neuromuscular Diseases · 2015 · 91 citations · Full text

Life Sciences, Genetics, Neurology +12